U.S. markets closed

Instil Bio, Inc. (TIL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
19.42+0.02 (+0.10%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close19.40
Open19.54
Bid18.88 x 1300
Ask20.00 x 1200
Day's Range19.19 - 19.98
52 Week Range14.42 - 29.49
Volume399,780
Avg. Volume352,167
Market Cap2.5B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-3.02
Earnings DateMay 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est28.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Do Hedge Funds Love Instil Bio, Inc. (TIL)?
    Insider Monkey

    Do Hedge Funds Love Instil Bio, Inc. (TIL)?

    The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than 866 world-class investment firms that we track and now have access to the collective wisdom contained in […]

  • Are Institutions Heavily Invested In Instil Bio, Inc.'s (NASDAQ:TIL) Shares?
    Simply Wall St.

    Are Institutions Heavily Invested In Instil Bio, Inc.'s (NASDAQ:TIL) Shares?

    The big shareholder groups in Instil Bio, Inc. ( NASDAQ:TIL ) have power over the company. Institutions will often hold...

  • Instil Bio to Present at the Jefferies Virtual Healthcare Conference
    GlobeNewswire

    Instil Bio to Present at the Jefferies Virtual Healthcare Conference

    DALLAS, June 01, 2021 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today announced that management will present a company overview at the Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 at 9:30 a.m. ET. A live webcast of the presentation may be accessed at: https://wsw.com/webcast/jeff174/til/1707183 or by visiting the News & Events section of the Instil Bio website at www.instilbio.com. An archived replay of the webcast will be available on the Company’s website for approximately 90 days following the presentation. About Instil Bio Instil Bio, Inc. (Nasdaq: TIL) is a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. Instil has assembled an accomplished management team with a successful track record in the development, manufacture, and commercialization of cell therapies. Using the company’s proprietary, optimized, and scalable manufacturing processes at its in-house manufacturing facilities, Instil is advancing its lead TIL product candidate, ITIL-168, for the treatment of advanced melanoma and other solid tumors as well as ITIL-306, a next-generation, genetically engineered TIL therapy for multiple solid tumors. For more information visit www.instilbio.com and LinkedIn. Contacts: Investor Relations1-972-499-3350investor.relations@instilbio.comwww.instilbio.comBrendan PayneStern Investor Relations1-212-362-1200brendan.payne@sternir.com